1.van Herk T, Brussee J, van den Nieuwendijk AM, van der Klein PA, IJzerman AP, Stannek C, Burmeister A, Lorenzen A.. (2003) Pyrazole derivatives as partial agonists for the nicotinic acid receptor., 46 (18):[PMID:12930155][10.1021/jm030888c]
2.Gharbaoui T, Skinner PJ, Shin YJ, Averbuj C, Jung JK, Johnson BR, Duong T, Decaire M, Uy J, Cherrier MC, Webb PJ, Tamura SY, Zou N, Rodriguez N, Boatman PD, Sage CR, Lindstrom A, Xu J, Schrader TO, Smith BM, Chen R, Richman JG, Connolly DT, Colletti SL, Tata JR, Semple G.. (2007) Agonist lead identification for the high affinity niacin receptor GPR109a., 17 (17):[PMID:17588745][10.1016/j.bmcl.2007.06.028]
4.Schmidt D, Smenton A, Raghavan S, Carballo-Jane E, Lubell S, Ciecko T, Holt TG, Wolff M, Taggart A, Wilsie L, Krsmanovic M, Ren N, Blom D, Cheng K, McCann PE, Gerard Waters M, Tata J, Colletti S.. (2009) Pyrazole acids as niacin receptor agonists for the treatment of dyslipidemia., 19 (16):[PMID:19592242][10.1016/j.bmcl.2009.06.054]